<DOC>
	<DOCNO>NCT02274025</DOCNO>
	<brief_summary>NovellusDx technology identifies tumor-specific driver mutation , unlike sequencing-based test , NovellusDx functional assay detects dis-regulated translocation mutate signal protein nucleus . This allow NovellusDx identify functionally-impactful driver mutation regardless whether mutation previously describe link tumor type .</brief_summary>
	<brief_title>NovellusDx Functional Profiling Oncogenic Mutations Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Patients suspect lung cancer eligible biopsy , surgical intervention pleural fluid suction Patients without lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Patient diagnose lung cancer</keyword>
</DOC>